期刊文献+

食管鳞癌组织中p57^kip2、cyclin D1和PCNA的表达及意义 被引量:3

The expression of p57^kip2, cyclin D1 and PCNA protein in esophageal cancer tissue and their significance
原文传递
导出
摘要 目的研究p57^kip2在食管鳞癌中的表达及意义,并探讨其与cyclin D1和PCNA在食管鳞癌中表达的相关性。方法采用免疫组织化学检测50例食管鳞癌组织及15例癌旁正常食管上皮组织中p57^kip2、cyclin D1、PCNA的表达;应用流式细胞术对这些组织的DNA含量和细胞周期分布进行分析。结果免疫组织化学:p57^kip2在食管鳞癌中的阳性表达率低于癌旁正常组织(P〈0.01),与癌组织的分化程度、浸润深度和淋巴结转移有关(P〈0.05);cyclin D1在食管鳞癌中的阳性表达率高于癌旁正常组织(P〈0.01),与癌组织的浸润深度和淋巴结转移有关(P〈0.05),与癌组织的分化程度无关(P〉0.05);PCNA在食管鳞癌中的阳性表达率高于癌旁正常组织(P〈0.01),与癌组织的分化程度、浸润深度和淋巴结转移有关(P〈0.05)。p57^kip2和cyclin D1、p57^kip2和PCNA之间表达负相关(r=-0.429,r=-0.585,P〈0.01)。流式细胞术:与癌旁正常组织相比,癌组织中DNA含量增高,异倍体细胞增加(P〈0.01);G0/G1期细胞减少,而S期和G2/M期细胞增多,增殖指数(PI)高于癌旁正常组织(P〈0.01)。结论p57^kip2低表达与cyclin D1和PCNA高表达可能与食管鳞癌的发生发展有关。 Objective To investigate the expression and significance of p57^kip2 in the esophageal cancer tissue, and the relationship between cyclin D1 and PCNA. Methods Immunohistochemistry S-P method was used to detect the expression of p57^kip2 , cyclin D1 and PCNA protein in 50 cases of esophageal cancer tissue and 15 cases of adjacent esophageal tissue. The change of DNA content and cell cycle distribution were analyzed by flow cytometry( FCM ). Results The percentage of p57^kip2 positive-expression in esophageal cancer tissue was lower than that in adjacent esophageal tissue( P 〈0. 01 ). There was a correlation between the expression of p57^kip2 and tumor cell differentiation, depth of invasion and lymph node metastasis( P 〈0.05 ). The percentage of cyclin D1 positive-expression in tumor tissue was higher than that in adjacent esophageal tissue ( P 〈 0.01 ). There was a correlation between the expression of cyclin D1 and depth of invasion, lymph node metastasis( P 〈 0. 05 ), but was not correlated with tumor cell differentiation( P 〉 0. 05 ). The percentage of PCNA positive-expression in tumor tissue was higher than that in adjacent esophageal tissue ( P 〈0.01 ), and was correlated with tumor cell differentiation, depth of invasion and lymph node metastasis ( P 〈 0. 05 ). There was negative correlation among the expression of p57^kip2 , cyclin D1 and PCNA ( r = - 0. 429, r = - 0. 585, P 〈 0. 01 ). Flow cytometry showed that DNA content and heteroploid cell increased in the esophageal cancer( P 〈0. 01 ). The percentage of cells in G0/G1 phase decreased, but S and G2/M phase increased. The proliferation index (PI) in esophageal cancer tissue was higher than that in adjacent esophageal tissue ( P 〈0. 01 ). Conclusion The decreased expression of p57^kip2 and over-expression of cyclin D1 and PCNA may be related to genesis and progress of esophageal cancer.
出处 《中国医师杂志》 CAS 2007年第12期1585-1588,共4页 Journal of Chinese Physician
关键词 食管肿瘤/病理学 增殖细胞核抗原 细胞周期蛋白D1 基因 肿瘤抑制 Esophageal neoplasms/PA Proliferating cell nuclear antigen Cyclin D1 Genes,tumor suppressor
  • 相关文献

参考文献7

  • 1Matsuooka S,Edwards MS,Bai C,et al.p57^kip2 structurally distinct member of the p21cip1-CDK inhibitor family,is a candicate tumor suppressor gene.Gene Dev,1995,9(6):650-662.
  • 2Yokoo T,Toyoshima H,Miura M,et al.p57^kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus.Biol Chem,2003,278(52):52919-52923.
  • 3Matsumoto M,Farihata M,Ohsuki Y,et al.Immunohistochemical characterization of p57^kip2 expression in human esophageal squamous cell carcinoma.Anticancer Res,2000,20(3B):1947-1952.
  • 4Sui L,Dong Y,Ohno M,et al.Expression of p57^kip2 and its clinical relevace in epithelial ovarian tumors.Anticancer Res,2002,22(6A):3191-3196
  • 5Ito Y,Takeda T,Sasaki Y,et al.Expression of p57^kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.Liver,2002,22(2):145-149.
  • 6岳辉,张宁,冯新莉,麻树人,宋福林,杨明,唐谊海.胰腺癌组织中p57^(kip2)、cyclin E和PCNA表达与临床病理因素的关系[J].癌症,2003,22(7):705-709. 被引量:11
  • 7Taftachi R,Ayhan A,Ekici S,et al.Proliferating-cell nuclear antige(PCNA)as an independent prognostic marker in patients after prostatectomy:a comparison of PCNA and ki-67.BJU Int,2005,94(4):650-654.

二级参考文献21

  • 1Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274: 1672-1677.
  • 2Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs) [J]. J Oncogene,1995, 11:211 -219.
  • 3Kamb A. Cell-cycle regulators and cancer[J]. J Trends Genet,1995, 11: 136- 140.
  • 4Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^kipl in multistage colorectal carcinogenesis[J].Cancer Res, 1998, 58:114 - 122.
  • 5Hunter T, Pines J. Cyelins and cancer Ⅱ: Cyclins and CDK inhibitors come of age[J]. Cell, 1994,79:573 -576.
  • 6Clurman BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87:1499 - 1504.
  • 7Matsuoka S, Edwards MC, Bai C, et al. p57^juo2 a structurally distinct member is a candidate tumor suppressor gene[J]. Genes Dev, 1995, 9:650 - 662.
  • 8Orlow 1, lavarone A, Crider-Miller SJ, et al. Cyclin-dependent kinase inhibitor p57^kip2 in soft tissue sarcoma and Wilms tumor[J].Cancer Res, 1996, 56:1219 - 1221.
  • 9Lee MH, Reynisdottir I, Massague J. Cloning of p57^kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distrlbution[J]. Genes Dev, 1995, 9:639-649.
  • 10Kondo M, Matsuka S, Uchida K, et al. Selective maternal allele loss in human lung cancers of the maternally expressed p57^kip2 gene at 11p15.5[J]. Oncogen, 1996,12:1365-1368.

共引文献10

同被引文献33

  • 1周正平,王进京,郑洪,苏俊,肖庆邦.乳腺浸润性导管癌中cyclinD_1、p57^(KIP2)的表达及意义[J].肿瘤防治研究,2005,32(8):476-478. 被引量:6
  • 2李卉,卢晓梅,赵学信,徐淑永,庞作良,陈艳,王洪江,武贵臻,库热西.玉努斯,关亚群,胡汉华,周新,刘旭,李惠武.Survivin、CyclinD1基因在哈萨克族食管癌中表达及其意义的研究[J].新疆医科大学学报,2007,30(6):560-562. 被引量:7
  • 3Sherr CJ. Cancer cell cycles[ J]. Science, 1996,274 : 1672.
  • 4Ito Y, Yoshida H, Nakano K,et al. Expression of p57^Kip2 protein in normal and neoplastic thyroid tissues[J]. Int J Mol Med,2002, 9:373.
  • 5Ito Y, Takeda T, Sasaki Y, et al. Expression of p57^Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma [ J ]. Liver,2002,22 : 145.
  • 6Lee MH, Reynisdottir I, Massague J. Cloning of p57^kip2 , a cyclindependent kinase inhibitor with unique domain instructure and tissued distribution [ J ]. Genes Dev, 1995,9:639.
  • 7Lai S, Goepfert H, Gillenwater AM, et al. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57^kip2 gene in head and neck squamous cell carcinoma [ J ]. Clin Cancer Res,2000,6:3172.
  • 8Matsuoka S,Edwards MS,Bai C ,et al. p57^kip2 ,a structurally distinct member of the p21cipl Cdk inhibitor family, is a candicate tumor suooressor gene[J. Genes Dev, 1995,9:650.
  • 9Nakamura M, Konishi N, Hiasa Y, et al. Frequent alterations of cell-cycle regulators in astrocytic tumors as detected by molecular genetic and immunohistochemical analyses [ J ]. Brain Tumor Pathol, 1998,15 : 83.
  • 10Tan H,Ye K,Wang Z,Tang H.CD147 expression asasignificant prognosic factor in differentiated thyroid carcinoma.Transl Res,2008,152(3):143-149.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部